RenovoRx is a biopharmaceutical company that works on therapies for solid tumors. They are currently in Phase III clinical trials for their lead product, RenovoGem, which is a drug and device combination for pancreatic cancer treatment. The company was founded in 2009 and has its headquarters in California.